FAST vs PPCB · P/E 43, rev $7.55B vs P/E 0.0, $3.9M cap
Fastenal Company (FAST) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
PPCB does not have a complete income-statement cache yet.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the FAST and PPCB stock pages for the full models.
Not investment advice.